Intellectual Property

On September 9, 2020, Genentech, Inc. and JHL Biotech, Inc. filed a stipulation for entry of a proposed consent judgment and permanent injunction as to JHL Biotech, Inc.  That proposed consent judgment and permanent injunction is the result of the parties’ June 18, 2020 settlement agreement, in which JHL represented that it had ceased and abandoned development and/or clinical trials of JHL 1101 (rituximab), JHL 1921 and JHL 1922 (dornase alfa), JHL 1149 (bevacizumab),…
What can be said for fast food is that, for all the franchises and chains that exist, there are only but a few options on offer, and that the distinction is in the differentiation. In that way, fast food isn’t all that different from any other industry; many make similar products, and where they get the edge is in their own “special sauce” that puts them above the rest, be it process or branding or…

Intellectual Property Blogs